Skip to main content
;

INDU Committee Meeting

Notices of Meeting include information about the subject matter to be examined by the committee and date, time and place of the meeting, as well as a list of any witnesses scheduled to appear. The Evidence is the edited and revised transcript of what is said before a committee. The Minutes of Proceedings are the official record of the business conducted by the committee at a sitting.

For an advanced search, use Publication Search tool.

If you have any questions or comments regarding the accessibility of this publication, please contact us at accessible@parl.gc.ca.

Previous day publication Next day publication

Minutes of Proceedings

43rd Parliament, 1st Session
Meeting 20
Monday, June 1, 2020, 11:05 a.m. to 1:03 p.m.
Webcast
Presiding
Sherry Romanado, Chair (Liberal)

• Simon-Pierre Savard-Tremblay (Bloc Québécois)
• Julie Vignola (Bloc Québécois)
Library of Parliament
• Sarah Lemelin-Bellerose, Analyst
• Francis Lord, Analyst
As an individual
• Arthur McDonald, Gordon and Patricia Gray Chair in Particle Astrophysics, Professor Emeritus, Nobel Physics Laureate 2015, Department of Physics, Engineering Physics and Astronomy, Queen's University
Bidali
• Eric Kryski, Chief Executive Officer and Co-Founder
Canadian Nuclear Laboratories
• Joe McBrearty, President and Chief Executive Officer
Dynamite Network
• Jeff Musson, President and Chief Executive Officer
SNOLAB
• Nigel Smith, Executive Director
StarFish Medical
• Scott Phillips, Chief Executive Officer
• John Walmsley, Executive Vice-President, Strategic Relationships
TRIUMF
• Jonathan Bagger, Director
Pursuant to the orders of reference of Saturday, April 11, 2020, and Tuesday, May 26, 2020, the committee resumed its study of the COVID-19 pandemic.

The witnesses made statements and answered questions.

Motion

Michelle Rempel Garner moved, — That, given the House motion made last week granted the committees power to study outside their usual scope, the Standing Committee on Industry, Science, and Technology conduct a study on Investment Canada Act; that this study determine the extent to which companies within strategic Canadian industries have been devalued as a result of the COVID-19 crisis; the extent to which foreign buyouts may occur; determine whether the current Investment Canada Act valuation thresholds is adequate to trigger a net benefit review given the potential extreme devaluation of companies within strategic Canadian industries; determine whether Canada should place a temporary moratorium on acquisitions from state owned enterprises of authoritarian countries; that this study consist of no less than four meetings; that this study be completed by June 21, 2020; that the Committee table its findings; and that the Government table a comprehensive response.

Amendment

Lloyd Longfield moved, — That the motion be amended by replacing the words “by June 21, 2020” with the following “after the completion of the study of the Canadian Response to the COVID-19 Pandemic”.

Debate arose thereon.

The question was put on the amendment of Lloyd Longfield and it was negatived on the following recorded division:

YEAS: Ali Ehsassi, Majid Jowhari, Emmanuella Lambropoulos, Lloyd Longfield — 4;

NAYS: Earl Dreeshen, Tracy Gray, Sébastien Lemire, Brian Masse, Jeremy Patzer, Michelle Rempel Garner — 6.

The question was put on the motion and it was agreed to on the following recorded division:

YEAS: Earl Dreeshen, Tracy Gray, Sébastien Lemire, Brian Masse, Jeremy Patzer, Michelle Rempel Garner — 6;

NAYS: Ali Ehsassi, Nathaniel Erskine-Smith, Majid Jowhari, Emmanuella Lambropoulos, Lloyd Longfield — 5.

At 1:03 p.m., the committee adjourned to the call of the Chair.



Michael MacPherson
Clerk of the Committee